Unlocking the Value of Combination Therapies
![unlocking the value of combination therapies](https://www.ohe.org/wp-content/uploads/2024/07/unlocking-the-value-of-combination-therapies-scaled.jpeg)
Biosimilars have similar, but not identical, structures to branded biologic drugs. Being comparable, but not interchangeable, they can differ in cost-effectiveness and accessibility. Increased competition, however, can reduce healthcare system costs.